Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subcutaneous Immune Globulin (SCIG 20%) and Facilitated Subcutaneous Immunoglobulin (fSCIG) Treatment in Polish Paediatric Patients With Primary Immunodeficiencies (PID) - Retrospective Medical Chart Review Study

NCT04636502 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT04636502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04636502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subcutaneous Immune Globulin (SCIG 20%) and Facilitated Subcutaneous Immunoglobulin (fSCIG) Treatment in Polish Paediatric Patients With Primary Immunodeficiencies (PID) - Retrospective Medical Chart Review Study
Lead sponsor
Shire
Phase
Observational
Overall status
Completed
Start date
February 8, 2021
Completion date
September 14, 2021
Enrollment
96 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

primary immunodeficiencies (pid)